BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26062789)

  • 1. Development of new methods for determining the heparanase enzymatic activity.
    Melo CM; Tersariol IL; Nader HB; Pinhal MA; Lima MA
    Carbohydr Res; 2015 Aug; 412():66-70. PubMed ID: 26062789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of both colorimetric and fluorescence heparinase activity assays using fondaparinux as substrate.
    Schiemann S; Lühn S; Alban S
    Anal Biochem; 2012 Aug; 427(1):82-90. PubMed ID: 22579846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeled heparan sulfate immobilized on microplate as substrate for the detection of heparanase activity.
    Nardella C; Steinkühler C
    Anal Biochem; 2004 Sep; 332(2):368-75. PubMed ID: 15325306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard.
    Chhabra M; Ferro V
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30441818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Enzymatic Activity Assay for Heparanase That Is Useful for Evaluating Clinically Relevant Inhibitors and Studying Kinetics.
    Hammond E; Ferro V
    Methods Mol Biol; 2023; 2619():227-238. PubMed ID: 36662473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-faceted substrate specificity of heparanase.
    Peterson SB; Liu J
    Matrix Biol; 2013 Jun; 32(5):223-7. PubMed ID: 23499529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple and rapid assay for heparanase activity using homogeneous time-resolved fluorescence.
    Enomoto K; Okamoto H; Numata Y; Takemoto H
    J Pharm Biomed Anal; 2006 Jun; 41(3):912-7. PubMed ID: 16495030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1H NMR spectroscopic studies establish that heparanase is a retaining glycosidase.
    Wilson JC; Laloo AE; Singh S; Ferro V
    Biochem Biophys Res Commun; 2014 Jan; 443(1):185-8. PubMed ID: 24291708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase.
    Levy-Adam F; Abboud-Jarrous G; Guerrini M; Beccati D; Vlodavsky I; Ilan N
    J Biol Chem; 2005 May; 280(21):20457-66. PubMed ID: 15760902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing of potential glycan-based heparanase inhibitors in a fluorescence activity assay using either bacterial heparinase II or human heparanase.
    Schoenfeld AK; Vierfuß S; Lühn S; Alban S
    J Pharm Biomed Anal; 2014 Jul; 95():130-8. PubMed ID: 24667567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
    Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
    Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening.
    Hammond E; Li CP; Ferro V
    Anal Biochem; 2010 Jan; 396(1):112-6. PubMed ID: 19748475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human heparanase nuclear localization and enzymatic activity.
    Schubert SY; Ilan N; Shushy M; Ben-Izhak O; Vlodavsky I; Goldshmidt O
    Lab Invest; 2004 May; 84(5):535-44. PubMed ID: 15034597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrafiltration-based assay for heparanase activity.
    Tsuchida S; Podyma-Inoue KA; Yanagishita M
    Anal Biochem; 2004 Aug; 331(1):147-52. PubMed ID: 15246007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights into heparanase activity using a fluorogenic heparan sulfate disaccharide.
    Wu L; Wimmer N; Davies GJ; Ferro V
    Chem Commun (Camb); 2020 Nov; 56(89):13780-13783. PubMed ID: 33073275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of heparanase from a rat parathyroid cell line.
    Podyma-Inoue KA; Yokote H; Sakaguchi K; Ikuta M; Yanagishita M
    J Biol Chem; 2002 Sep; 277(36):32459-65. PubMed ID: 12077130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-reducing end labeling of heparan sulfate via click chemistry and a high throughput ELISA assay for heparanase.
    Wu ZL; Huang X; Ethen CM; Tatge T; Pasek M; Zaia J
    Glycobiology; 2017 Jun; 27(6):518-524. PubMed ID: 28025251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial expression and functional reconstitution of human heparanase.
    Winkler S; Schweiger D; Wei Z; Rajkovic E; Kungl AJ
    Carbohydr Res; 2014 May; 389():72-7. PubMed ID: 24656445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric fluorescent heparin as one-step FRET substrate of human heparanase.
    Sistla JC; Morla S; Alabbas AB; Kalathur RC; Sharon C; Patel BB; Desai UR
    Carbohydr Polym; 2019 Feb; 205():385-391. PubMed ID: 30446119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular model of human heparanase with proposed binding mode of a heparan sulfate oligosaccharide and catalytic amino acids.
    Sapay N; Cabannes E; Petitou M; Imberty A
    Biopolymers; 2012 Jan; 97(1):21-34. PubMed ID: 21780097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.